Enorama Pharma (Sweden) Price History

ERMA Stock  SEK 3.55  0.06  1.66%   
If you're considering investing in Enorama Stock, it is important to understand the factors that can impact its price. As of today, the current price of Enorama Pharma stands at 3.55, as last reported on the 29th of November, with the highest price reaching 3.70 and the lowest price hitting 3.55 during the day. Enorama Pharma AB secures Sharpe Ratio (or Efficiency) of -0.0394, which denotes the company had a -0.0394% return per unit of risk over the last 3 months. Enorama Pharma AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enorama Pharma's Standard Deviation of 5.31, mean deviation of 3.98, and Variance of 28.15 to check the risk estimate we provide.
  
Enorama Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0394

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsERMA

Estimated Market Risk

 5.24
  actual daily
46
54% of assets are more volatile

Expected Return

 -0.21
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.04
  actual daily
0
Most of other assets perform better
Based on monthly moving average Enorama Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enorama Pharma by adding Enorama Pharma to a well-diversified portfolio.

Enorama Pharma Stock Price History Chart

There are several ways to analyze Enorama Stock price data. The simplest method is using a basic Enorama candlestick price chart, which shows Enorama Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 17, 20245.68
Lowest PriceNovember 28, 20243.55

Enorama Pharma November 29, 2024 Stock Price Synopsis

Various analyses of Enorama Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enorama Stock. It can be used to describe the percentage change in the price of Enorama Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enorama Stock.
Enorama Pharma Price Daily Balance Of Power(0.40)
Enorama Pharma Price Rate Of Daily Change 0.98 
Enorama Pharma Price Action Indicator(0.11)

Enorama Pharma November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Enorama Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Enorama Pharma intraday prices and daily technical indicators to check the level of noise trading in Enorama Stock and then apply it to test your longer-term investment strategies against Enorama.

Enorama Stock Price History Data

The price series of Enorama Pharma for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 2.13 with a coefficient of variation of 10.45. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.23. The median price for the last 90 days is 4.15. The company completed 1726:1687 stock split on 29th of October 2018.
OpenHighLowCloseVolume
11/29/2024
 3.60  3.70  3.55  3.55 
11/28/2024 3.60  3.70  3.55  3.55  1,918 
11/27/2024 3.88  3.88  3.61  3.61  8,296 
11/26/2024 3.89  3.89  3.58  3.76  10,117 
11/25/2024 3.77  3.94  3.63  3.89  4,112 
11/22/2024 3.88  3.99  3.77  3.77  13,773 
11/21/2024 3.86  3.89  3.75  3.86  16,181 
11/20/2024 4.25  4.25  3.88  4.09  10,707 
11/19/2024 4.99  4.99  4.05  4.23  11,553 
11/18/2024 4.02  4.50  3.91  3.91  12,969 
11/15/2024 3.65  4.01  3.60  3.92  9,946 
11/14/2024 4.00  4.02  3.74  3.95  431.00 
11/13/2024 3.98  4.25  3.78  3.99  12,311 
11/12/2024 3.81  4.25  3.61  3.81  71,592 
11/11/2024 3.61  3.93  3.58  3.79  10,383 
11/08/2024 3.84  3.84  3.61  3.62  9,416 
11/07/2024 3.84  3.84  3.61  3.84  3,914 
11/06/2024 3.71  3.94  3.71  3.84  11,187 
11/05/2024 3.96  3.96  3.60  3.94  5,086 
11/04/2024 3.59  3.88  3.32  3.60  1,084 
11/01/2024 4.00  4.00  3.68  3.68  2,160 
10/31/2024 4.00  4.00  3.88  3.88  2,922 
10/30/2024 3.78  4.12  3.78  4.04  6,332 
10/29/2024 3.84  4.17  3.78  3.78  18,747 
10/28/2024 3.94  4.59  3.81  3.84  26,544 
10/25/2024 3.97  3.97  3.75  3.94  1,777 
10/24/2024 3.82  3.96  3.73  3.96  7,583 
10/23/2024 3.60  4.07  3.50  3.85  8,182 
10/22/2024 4.28  4.69  3.91  3.92  17,169 
10/21/2024 4.28  4.30  4.00  4.00  8,209 
10/18/2024 3.99  4.29  3.99  4.10  6,517 
10/17/2024 4.61  4.61  3.92  4.00  45,799 
10/16/2024 4.78  4.78  4.17  4.61  3,031 
10/15/2024 4.07  4.80  4.07  4.15  5,308 
10/14/2024 4.27  4.27  4.07  4.07  3,054 
10/11/2024 4.00  4.27  4.00  4.20  7,555 
10/10/2024 4.16  4.20  4.16  4.20  1,010 
10/09/2024 4.59  4.59  4.15  4.21  11,000 
10/08/2024 4.63  4.63  4.36  4.59  22,117 
10/07/2024 4.64  4.64  4.64  4.64  1,082 
10/04/2024 4.53  4.77  4.34  4.34  4,385 
10/03/2024 4.57  4.71  4.25  4.33  11,338 
10/02/2024 4.33  4.55  4.13  4.14  2,364 
10/01/2024 4.59  4.60  4.33  4.33  4,636 
09/30/2024 4.38  4.59  4.30  4.50  3,945 
09/27/2024 4.67  4.67  4.37  4.38  2,950 
09/26/2024 4.68  4.68  4.45  4.60  5,941 
09/25/2024 4.95  5.10  4.50  4.50  107,976 
09/24/2024 4.66  4.94  4.57  4.94  514.00 
09/23/2024 4.93  5.42  4.72  4.72  13,508 
09/20/2024 5.20  5.44  4.93  4.93  14,020 
09/19/2024 5.50  5.50  5.18  5.20  8,335 
09/18/2024 5.38  5.38  5.16  5.16  10,141 
09/17/2024 5.04  5.72  5.04  5.68  15,055 
09/16/2024 4.43  5.02  4.43  4.99  3,524 
09/13/2024 4.70  4.70  4.43  4.52  7,543 
09/12/2024 4.28  4.73  4.28  4.42  6,420 
09/11/2024 4.35  4.49  4.25  4.28  9,183 
09/10/2024 4.42  4.43  4.23  4.39  1,696 
09/09/2024 4.52  4.61  4.42  4.42  18,088 
09/06/2024 4.70  4.72  4.47  4.51  20,781 

About Enorama Pharma Stock history

Enorama Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enorama is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enorama Pharma AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enorama Pharma stock prices may prove useful in developing a viable investing in Enorama Pharma
Enorama Pharma AB , a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. Enorama Pharma AB is a subsidiary of Swede Unipharma AB. Enorama Pharma is traded on Stockholm Stock Exchange in Sweden.

Enorama Pharma Stock Technical Analysis

Enorama Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Enorama Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Enorama Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Enorama Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Enorama Pharma's price direction in advance. Along with the technical and fundamental analysis of Enorama Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enorama to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Enorama Stock Analysis

When running Enorama Pharma's price analysis, check to measure Enorama Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enorama Pharma is operating at the current time. Most of Enorama Pharma's value examination focuses on studying past and present price action to predict the probability of Enorama Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enorama Pharma's price. Additionally, you may evaluate how the addition of Enorama Pharma to your portfolios can decrease your overall portfolio volatility.